Trial Profile
Reverse Cholesterol Transport in Humans
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia; Ischaemic heart disorders
- Focus Pharmacodynamics
- 05 May 2016 Status changed from not yet recruiting to completed.
- 28 May 2012 New trial record